AXIM BIOTECHNOLOGIES, INC. Income Statement
AXIM|9 years of annual SEC 10-K data (FY2011-FY2023)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 9 fiscal years. All figures from audited SEC 10-K filings.
AXIM BIOTECHNOLOGIES, INC. reported $39,518 in revenue and $8M in net loss for FY2023. Revenue has grown at a 12.1% compound annual rate over the past 12 years.
Based on SEC 10-K filings.
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -18.18 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2023 | FY2022 | FY2018 | FY2017 | FY2016 | FY2015 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $39.5K | $8.9K | $195.6K | $47.6K | $47.1K | $49.1K | $75.0K | $43.3K | $10.0K |
| Cost of Revenue | - | - | $8.5K | $42.9K | $154.1K | $50.4K | - | - | - |
| Gross Profit | - | - | $187.1K | $4.7K | -$107.1K | -$1.2K | - | - | - |
| SG&A Expense | $2.2M | $4.1M | $3.2M | $1.8M | $3.4M | $9.5M | - | - | - |
| R&D Expense | $125.5K | $153.7K | $2.1M | $1.4M | $235.6K | $571.5K | - | - | - |
| Operating Income | -$2.8M | -$4.7M | -$5.0M | -$3.1M | -$3.8M | -$10.0M | - | - | - |
| Interest Expense | $140.0K | $261.5K | $456.1K | $315.0K | $275.7K | $43.2K | - | - | - |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | - | - | - |
| Net Income | -$8.1M | -$6.2M | -$6.8M | -$4.2M | -$5.8M | -$10.1M | -$89.2K | -$14.9K | -$2.8K |
| EPS (Basic) | -$0.04 | $0.12 | - | - | - | - | - | - | - |
| EPS (Diluted) | -$0.04 | $0.12 | -$0.08 | -$0.17 | -$0.27 | -$0.02 | - | - | $0.00 |
| Shares Outstanding | 192.4M | 138.1M | 54.6M | 52.5M | 39.6M | 33.0M | 33.0M | 33.0M | 20.0M |
| Gross Margin | - | - | 95.7% | 9.9% | -227.5% | -2.5% | - | - | - |
| Operating Margin | -6961.0% | -52425.6% | -2574.5% | -6619.5% | -7988.8% | -20451.3% | - | - | - |
| Profit Margin | -20395.0% | -70343.1% | -3453.1% | -8761.7% | -12346.0% | -20539.2% | -119.0% | -34.4% | -27.9% |